Gene Query: FBXL4

Dataset Description Geneva Score
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 31.6
Oncogenic MYC induces a dependency on the spliceosome in human cancer 21.92
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization [RNA-Seq] 17.37
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization 17.37
Whole-transcriptome profilings between a pair of HCA7-derived KRAS-wildtype cetuximab sensitive and resistant colon cancer cells from 3D culture 14.47
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma non-targeting shRNA negative control (SHC002V) with puromycin selection RNAseq 11.71
Transcriptome Analysis of PBMCs in peripheral blood of patients with hepatocellular carcinoma 10.86
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 10.49
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 10.49
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits [mRNA-Seq] 9.89
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits 9.89
DUX4 recruits p300/CBP through its C-terminus and induces global H3K27 acetylation changes 9.4
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 8.96
HNRNPM-regulated splicing dependencies in prostate cancer 8.96
LNCaP treated with iBET 8.72
Evolving Spindlin1 Small Molecule Inhibitors Using Protein Microarrays 8.37
FUS mutant human motoneurons transcriptome analysis reveals altered pathways and impairment of microRNA function 8.33
RNA expression in primary huamn muscle cells treated with 1,25(OH)2D3 or vehicle 8.16
mRNA and miRNA expression in primary human muscle cells treated with 1,25(OH)2D3 or vehicle 8.16
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 7.87
High-throughput RNA sequencing of human preovulatory cumulus and mural granulosa cells (mRNA) 7.86
Small RNA-seq of human granulosa cells reveals miRNAs in FSHR and aromatase genes 7.86
Illumina Total RNA-seq in HeLa 7.69
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 7.45
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes 7.37
Global transcriptome analysis of HAP1 cells 7.24
RNA-seq of YB5 cells treated with Proscillaridin A 7.13
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 7.01
Dtx3L and Androgen Signaling in Prostate Cancer 6.98
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs 6.93
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 6.82
Transcriptomic characterization of a human in vitro model of arrhythmogenic cardiomyopathy under topological and mechanical stimuli 6.77
Cell responses to dysregulated VZV-induced cell-cell fusion 6.74
Activating PAX Gene Family Paralogs to Complement PAX5 Leukemia Driver Mutations 6.71
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 6.58
RNA-sequencing of human liver tissue 6.36
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 6.13
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 5.98
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 5.98
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 5.96
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 5.91
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (mRNA-Seq) 5.86
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 5.74
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 5.74
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 5.72
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 5.71
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 5.71
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (chromatin-bound RNA-seq) 5.66
Generation and functional characterization of MDSC-like cells 5.58
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 5.45
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 5.45
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 5.42
Gene expression in skeletal muscle in older individuals subject to ten days of complete bed rest. 5.28
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 5.21
Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors That Can Function as a Cell of Origin for Prostate Cancer 5.18
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 5.11
Genomic deletion of malic enzyme 2 confers collateral lethality in pancreas cancer 5.06
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 5.0
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 4.96
Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 4.93
RNA-seq in untreated and flagellin-treated Human Intestinal Myofibroblast cells (HIMF) 4.88
Effect of TUNAR silencing and GSK3 inhibition on human b-cell transcriptome 4.84
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing Mbnl1 [RNA-seq & Ribo-seq] 4.83
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing MBNL1 4.83
Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200 4.82
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 4.81
Impact of dieldrin on transcription in Jurkat T cells 4.8
RNA-Seq study of Cell lines rendered resistant to idelalisib and ibrutinib 4.76
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells 4.74
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [d7+d14] 4.73
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 4.65
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs 4.64
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq B-ALL) 4.63
Hypoxic transcriptome of SQ20B human head and neck cancer cells 4.59
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 4.5
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 4.5
Integrin signaling regulates YAP/TAZ to control skin homeostasis 4.49
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 4.47
mRNA-Seq profiling of human developing kidney 4.46
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 4.46
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 4.33
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 4.29
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 4.29
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 4.28
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 4.28
C9orf72 Intermediate Repeats are Associated with Corticobasal Degeneration, Increased C9orf72 Expression and Disruption of Autophagy 4.22
single cell RNA-seq from GM12878 (ENCSR673UIY) 4.2
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (wtRNA-Seq) 4.15
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 4.11
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 4.05
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 4.02
Gene expression in PANC1 cells treated with Rakicidin 3.95
Alternative splicing of differentiated myeloid cell transcripts after infection by Anaplasma phagocytophilum impacts a selective group of cellular programs 3.94
MicroRNA-125a-5p overexpression in human macrophages 3.93
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 3.88
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 3.87
NEUROD1 dependent gene regulation in murine pancreatic endocrine cells and human stem cell derived insulin producing cells 3.86
Rna-seq transcriptome data for insulin-GFP+ cells differentiated from NEUROD1 knock out and NEUROD1+/+ control human embryonic stem cells. 3.86
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 3.85
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 3.85
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL [RNA-seq] 3.82
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL 3.82
Platelet Transcriptome Profiling in HIV and ABCC4 as a Biomarker of Platelet Activity 3.8
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 3.79
Loss of CREBBP results in gene expression repression in lymphoma cells 3.75
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 3.75
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 3.75
SETBP1-WT and SETBP1-G870S epigenetic landscapes 3.75
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 3.73
HNRNPL and its RNA Targets in Prostate Cancer 3.73
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 3.73
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 3.72
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 3.7
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 3.7
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 3.68
RNA sequencing of primary human platelets and in vitro cell lines 3.66
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 3.63
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 3.62
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 3.62
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 3.54
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 3.52
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor 3.51
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 3.51
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 3.51
The cohesin release factor WAPL restricts chromatin loop extension. 3.51
MYCL and EP400 are required for Max and MCPyV mediated gene activation 3.51
Transcriptome profiling of a mouse model of alveolar soft part sarcoma 3.49
3’ Uridylation Expands miRNA Target Repertoire 3.48
An alternative CTCF isoform antagonizes canonical CTCF occupancy and changes chromatin architecture to promote apoptosis 3.45
Genome-wide maps of chromatin state and mRNA expression patterns in leukemic cell lines 3.44
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 3.43
Proteolytic cleavage by taspase1 and the regulation of the stability of MLL1 3.43
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 3.41
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 3.41
SLIGRL-induced gene expression changes in NHEK cells 3.41
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 3.39
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 3.39
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 3.38
RNA-sequencing of formalin fixed human primary melanoma tissue 3.36
Profiles of Long Noncoding RNAs in Human Naive and Memory T Cells 3.32
Genome-wide discovery of human splicing branchpoints 3.32
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 3.32
Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+ breast cancer 3.26
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells 3.24
Identifying ASCL1 target genes in primary GBM stem cell cultures [RNA-seq] 3.24
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition [RNA-seq] 3.22
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition 3.22
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 3.21
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 3.19
Expression level comparison under dividing and quiescent states in human primary fibroblasts 3.17
Convergent roles of ATF3 and CSL in chromatin control of CAF activation [RNA-seq] 3.17
Convergent roles of ATF3 and CSL in chromatin control of CAF activation 3.17
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 3.15
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 3.14
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 3.13
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 3.13
Resistance to BET inhibitor leads to new therapeutic vulnerabilities in castration resistant prostate cancer 3.13
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 3.11
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 3.11
PNET animal model: new insights (II) 3.11
Endothelial gene expression analysis 3.1
Total RNA deep sequencing (ribosomal depleted) of human umbilical vein endothelial cells exposed to hypoxia (0.2%) for 12h and 24h or kept under normoxic conditions. 3.1
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 3.05
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 3.05
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 3.03
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 3.03
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 3.02
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 3.02
Effect of CHKA knockdown on C4-2 cell transcriptome 3.01
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 2.97
Biological effect of chronic mistranslation in mammalian cells 2.97
Knockdown of ADNP in HCT116 colon cancer cells 2.97
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 2.97
Widespread intronic polyadenylation diversifies immune cell transcriptomes 2.96
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration 2.93
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 2.92
Transcriptomic analyssis following EHMT1/2 inhibition 2.91
Ebola virus (EBOV) infection of ARPE-19 cells 2.9
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [ZNF787] 2.88
The SUMO Pathway as a Therapeutic Option in Pancreatic Cancer 2.88
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 2.87
A Brain Penetrant Mutant IDH1 Inhibitor Provides In Vivo Survival Benefit 2.87
Gene expression changes caused by KRAS in MCF-10A 2.85
AKAP8 inhibits tumor metastasis by antagonizing EMT-associated RNA alternative splicing 2.84
Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia [shRNA] 2.84
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 2.84
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 2.84
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) 2.84
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 2.83
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 2.83
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies [RNA-Seq] 2.8
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies 2.8
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 2.79
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 2.79
RNA-seq Profiles in RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 2.77
RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 2.77
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 2.77
TAF1 is critical for AE driven leukemogenesis 2.76
TAF1 is critical for AE driven leukemogenesis [RNA-seq] 2.76
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia. 2.75
Analysis of gene expression in SKOV3 ovarian cancer cells after knockdown of the long non-coding RNA DNM3OS 2.74
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 2.73
RNAseq Analysis in glioblastoma cells treated with Mepazine 2.73
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 2.72
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 2.72
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 2.7
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 2.7
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 2.7
Tracking distinct RNA populations using efficient and reversible covalent chemistry 2.69
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 2.67
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 2.67
Global gene expression profiles of cardiomyocytes differentiated from human pluripotent stem cells (hiPSC-CMs) in 3D culture exposed to ethanol 2.64
Targeted inhibition of STAT/TET1 axis as a potent therapeutic strategy for acute myeloid leukemia 2.64
Transciptomic profiling of human fetal lung samples 2.64
Total RNA-seq in ALL-SIL upon TLX1 knockdown 2.62
Exercise-induced transcriptome changes in skeletal muscle adapted to aerobic training 2.62
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 2.62
RNA-seq of resting and activated CD4+ T cells +-JQ1 2.61
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation 2.6
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation [human cell line RNA-seq] 2.6
High-throughput RNA sequencing on circular RNA profiles of human pancreatic cancer cell lines and gemcitabine resistant pancreatic cancer cell lines. 2.59
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 2.58
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 2.58
Transcriptome of EMT induced MCF10A cells by TGFb treatment or SNAIL S6A expression. 2.57
Effect of digoxin treatment on the gene and alternative splice expression in human pluripotent stem cells- derived mesenchymal stem cells 2.57
JunB control of keratinocyte-mediated inflammation [RNA-seq] 2.53
RNA-Seq and ChIP-Seq reveals SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation 2.53
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 2.52
SETDB1 compacts the inactive X chromosome in part through silencing an enhancer in the IL1RAPL1 gene 2.5
MYC dependent mRNA translation shapes gene expression and cell biology 2.47
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 2.47
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 2.46
Developmental stage specific chromosome architecture in human erythroid cells 2.46
Age-Related Gene Expression Changes in Prostate Cancer Patients 2.45
Age-Related Gene Expression Changes in Prostate Cancer Patients [RNA-Seq] 2.45
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 2.44
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 2.44
The pause-initiation limit restricts transcription activation in human cells 2.43
Effect of PBK knockdown on C4-2 cell transcriptome 2.43
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress (Total RNA) 2.42
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 2.42
Global Mapping of Human RNA-RNA Interactions 2.4
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 2.38
Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify 2.37
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 2.29
Global reduction in H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 2.28
Epigenetic reprogramming of melanoma cells by vitamin C treatment 2.25
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 2.23
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 2.23
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 2.23
RNA deep sequencing analysis of human brain microvascular endothelial cells (ECs) treated with glioma-conditioned medium (glioma-CM) 2.23
RNA-seq and Microarray in Transcriptome Profiling of Anterior Cruciate Ligament Tears: Implications for Prognostic Biomarkers Discovery 2.18
Genome-scale identification of transcription factors that mediate an inflammatory network during breast cellular transformation 2.17
RNA-seq during MCF10A-ER-Src cell transformation and upon factor knockdowns 2.17
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 2.14
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 2.14
Heterogeneous effects of massive hypoxia pathway activation in kidney cancer 2.14
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 2.11
Patient-iPSC-derived kidney organoids show functional validation of a ciliopathic renal phenotype 2.1
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 2.1
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 2.09
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 2.09
Global transcript structure resolution of high gene density genomes through multi-platform data integration: Illumina RNA-Seq 2.07
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing 2.07
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 2.05
Differential expression analysis of RNA-seq data from melanocytes driven by tumor cell-derived exosomes 2.03
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis 2.02
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 2.02
Transcriptomic analysis of LSD1 2.02
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 2.01
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 2.01
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 1.98
DNA Methylation Reprograms Metabolic Gene Expression in End-Stage Human Heart Failure 1.96
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 1.89
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 1.89
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 1.89
Mining the stiffness-sensitive transcriptome in human vascular smooth muscle cells identifies long non-coding RNA stiffness regulators 1.87
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 1.87
The contribution of Alu exons to the human proteome 1.86
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 1.86
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 1.85
MeRIP-seq for heat shock in B-cell lymphoma cells 1.85
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 1.84
Gene expression in GBM with Cav3.2 inhibition 1.83
Novel Atherogenic Pathways from the Differential Transcriptiome Analysis of Diabetic Epicardial Adipose Tissue 1.82
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 1.8
Gene expression changes after LOC550643 silencing 1.78
The effect of Abl kinases on non-small cell carcinoma global transcriptome 1.76
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 1.72
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 1.71
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 1.7
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 1.68
Dynamic 3D chromosomal landscapes in acute leukemia 1.66
Dynamic 3D chromosomal landscapes in acute leukemia [RNA-Seq] 1.66
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 1.65
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 1.64
Transcriptomic profiling of human peripheral blood-derived mast cells 1.64
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 1.63
Transcriptome analysis of human cumulus cells reveals hypoxia as the main determinant of follicular senescence. 1.62
Comparing effects of perfusion and hydrostatic pressure on human chondrocytes using gene profiles 1.61
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 1.6
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 1.6
CD74 role in transcription regulation [RNA-seq] 1.6
CD74 role in transcription regulation 1.6
RNA-sequencing 1.59
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 1.58
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 1.58
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 1.57
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 1.56
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 1.54
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 1.53
Mapping interactions for the TNIP2 hub protein 1.53
Sequence dependency and regulatory function of dimeric NOTCH1/RBPJ complexes on coding and non-coding transcription in T-lymphoblastic leukemia 1.53
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 1.52
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 1.51
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 1.5
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 1.5
LIN28A Over-expression RNAseq 1.49
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 1.49
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 1.49
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 1.46
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 1.46
Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue 1.46
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 1.46
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis 1.45
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis [RNA-Seq_Hs] 1.45
Transcriptome profiling of self-renewing hESCs and multipotent mesoderm progenitor cells as a function of substrate stiffness 1.44
Effects of a nutritional supplement in older individuals subject to ten days of complete bed rest. 1.43
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp2] 1.41
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 1.4
Transcriptome analyses of human pancreatic islets and pseudoislets 1.39
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 1.37
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 1.37
High-throughput RNA sequencing on circular RNA profiles of human triple-negative breast cancer and adjacent normal tissues 1.33
RNA expression analysis upon JMJD1C depletion 1.32
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 1.32
UBE3A-mediated regulation of imprinted genes and epigenome-wide marks in human neurons 1.32
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 1.29
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 1.28
microRNAs with an AAGUGC seed motif constitute an integral part of a signaling network driving NSCLC cell proliferation 1.25
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 1.25
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 1.22
RNAseq in Alzheimer's Disease patients 1.22
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 1.21
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 1.2
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 1.2
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 1.2
Next Generation Sequencing Quantitative Analysis of Wild Type and AML1-ETO Related Fusion Circular RNA (F-CircAE) Knockdown Kasumi-1 Cells Transcriptomes 1.19
mRNA sequencing analysis of cultured human primary airway epithelial cells upon exposure to PMN exosomes 1.18
Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer 1.17
CircRNAome diversity in human mature B-cells, T-cells and monocytes 1.16
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 1.14
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 1.11
RNA sequencing of human mammary epithelial cells 1.08
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 1.08
Stage-specific regulation of the WNT/β-catenin pathway enhances differentiation of hESCs into hepatocytes 1.08
Persistence of stem cell metabolism in cancers as a failure of differentiation 1.07
Differentially expressed genes during pancreatic bud differentiation in cellular aggregates 1.06
Deep RNA sequencing of the human placental transcriptome 1.06
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells 1.06
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 1.03
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 1.03
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 1.03
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 1.03
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 1.03
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 1.01
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 1.01
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 1.01
STX4 Over-Expression in Human islets 1.0
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 1.0
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 1.0
CLIC5: a novel ETV6 target gene in childhood acute lymphoblastic leukemia 0.97
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 0.97
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 0.97
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 0.92
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 0.92
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines (mRNA-Seq) 0.92
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines 0.92
Regulation of poly(A) tail and translation during the somatic cell cycle 0.9
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 0.87
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 0.86
Transcriptome landscape of human primary monocytes response upon different ligand glucocorticoids 0.86
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 0.85
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours [RNA-seq] 0.81
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours 0.81
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 0.81
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 0.8
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 0.8
Zika Virus Has Oncolytic Activity against Glioblastoma Stem Cells 0.79
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 0.79
The transcriptome of Kawasaki Disease arteritis 0.78
Frailty in middle age is associated with race-specific changes to the transcriptome. 0.78
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells 0.77
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 0.77
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 0.76
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 0.76
Downregulation of LATS kinases alters p53 to promote cell migration 0.75
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 0.74
Pain-driven transcriptome changes in synovium of knee osteoarthritis patients 0.73
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 0.73
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 0.73
Modulation of nonsense-mediated decay by rapamycin 0.7
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 0.69
Primary Human B-cell Temporal Response to CD40L Stimulation 0.69
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 0.68
Human Bone Marrow Assessment by Single Cell RNA Sequencing, Mass Cytometry and Flow Cytometry [bulk] 0.67
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.67
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.67
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 0.66
Long non-coding RNA expression profile associated with malignant progression of oral submucous fibrosis 0.66
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing (Total RNA sequencing) 0.66
Targeted enhancer activation by a subunit of the integrator complex 0.64
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 0.64
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 0.64
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 0.63
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 0.63
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 0.63
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 0.62
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 0.59
Simultaneous detection and relative quantification of coding and non-coding RNA using a single sequencing reaction 0.59
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 0.58
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 0.57
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 0.56
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 0.55
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 0.54
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 0.54
eRNA: A graphic user interface-based tool for RNA sequencing data analysis [mRNA-Seq] 0.52
eRNA: A graphic user interface-based tool for RNA sequencing data analysis 0.52
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 0.51
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 0.51
Identification of a LIF-responsive replication-competent human β cell 0.49
Transcriptome of melanoma cell lines resistant to inhibition of the MAPK pathway. 0.49
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity 0.48
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 0.46
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 0.46
Expression patterns in chronic thromboembolic pulmonary hypertension 0.45
Transcriptome data from human endocrine cells recovered from mouse grafts with pre-engraftment controls 0.43
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 0.43
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 0.43
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. [RNA-Seq] 0.42
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. 0.42
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 0.42
Transcriptomic analysis of human macrophages in 3D 0.42
Differentially Expressed Genes for Atrial Fibrillation Identified using RNA Sequencing from Paired Human Left and Right Atrial Appendages. 0.39
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 0.38
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 0.38
Discovering human diabetes-risk gene function with genetics and physiological assays 0.36
Gene expression analysis of human hepatocellular cancers 0.36
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 0.35
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 0.34
Gene expression profiling of human iPS cell-derived podocytes and sorted human adult podocytes 0.34
Genome-wide Circadian Control of Transcription at Active Enhancers Regulates Insulin Secretion and Diabetes Risk 0.31
Pancreatic Beta Cell Enhancers Regulate Rhythmic Transcription of Exocyst Triggering and Diabetes 0.31
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug 0.31
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug [human] 0.31
A MYC/GCN2/eIF2alpha negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer 0.3
Differential susceptibility of human pleural and peritoneal mesothelial cells to asbestos exposure 0.3
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 0.29
Transcriptome analysis upon C6orf203 silencing 0.29
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 0.28
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 0.28
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes 0.28
Mesothelioma xenografts in nude mice: PBS treated versus pirfenidone treated 0.27
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 0.26
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 0.26
Transcriptome analysis of CNS leukemia 0.26
Transcriptional profiling identifies differential expression of long non-coding RNAs in Jo-1 associated and inclusion body myositis 0.26
Charaterization of genetic alterations and gene expression signatures found in BCR-ABL inhibitor-resistant KCL-22 subpopulations and single clones 0.25
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 0.24
Effect of BMP inhibition or stimulation of primary human keratinocytes 0.23
Single-cell ID-seq identifies BMP signaling as a driver of a late stage epidermal differentiation program. 0.23
Gene expression alterations of pancreatic intraepithlial neoplasia 0.23
Illumina HiSeq Sequencing on Breast cancer PDX samples 0.21
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.19
CRISPR/Cas9-mediated ASXL1 mutation in U937 cells perturbs myeloid differentiation 0.17
Kidney compartment specific eQTL studies highlight causal genes and pathways for renal disease development 0.13
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells 0.12
Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networks 0.12
Modeling Human Cancer-induced Cachexia (Human) 0.11
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 0.11
Human ovarian granulosa cell transcriptome 0.1
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 0.1
Total RNA-Seq data from leukemic patients with complex structural variants 0.09
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches [RNA-Seq] 0.08
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches 0.08
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [RNA-Seq] 0.08
RNA sequencing of bone marrow CD34+ cells from myelodysplastic syndrome patients with and without SF3B1 mutation and from healthy controls 0.07
Effects of plasticizers (bisphenol A, bisphenol AF) and an herbicide in MCF7 human breast cancer cells 0.06
Truncation of LOC100288798 (SLC38A4-AS) lncRNA in human haploid KBM7 cell line 0.05
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 0.05
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 0.04
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 0.04
A20 regulates canonical wnt-signaling through an interaction with RIPK4 0.03
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 0.02
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 0.02
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.01
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.01
Transcriptomic analysis of healthy donor and Sickle Cell Disease (SCD) hematopoietic stem/progenitor cells 0.01
The transcriptome and chromatin accessbility landscape of mammalian germline 0.01
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation